[Federal Register Volume 77, Number 81 (Thursday, April 26, 2012)]
[Notices]
[Pages 24968-24969]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2012-10083]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Cancer Institute; Notice of Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2) notice is hereby given of the following 
meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The purpose of this meeting is to evaluate requests 
for preclinical development resources, biologics, clinical assays and 
other developmental programs for potential new therapeutics for the 
treatment of cancer. The outcome of the evaluation will provide 
information to internal NCI committees that will decide whether

[[Page 24969]]

NCI should support requests and make available contract resources for 
development of the potential therapeutic to improve the treatment of 
various forms of cancer. The research proposals and the discussions 
could disclose confidential trade secrets or commercial property such 
as patentable material and personal information concerning individuals 
associated with the proposed research projects, the disclosure of which 
would constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; Clinical Assay Development Program (CADP).
    Date: July 31, 2012.
    Time: 8 a.m.-3 p.m.
    Agenda: To review grant applications for the CADP.
    Place: National Cancer Institute, NIH, Executive Plaza North, 
6130 Executive Boulevard, Room J, Rockville, MD 20852.
    Contact Person: Tracy G. Lively, Ph.D., Executive Secretary, 
Cancer Diagnosis Program (CADP), National Cancer Institute, NIH, 
6130 Executive Boulevard, EPN/6035A, Bethesda, MD 20892, 301-496-
8639, [email protected].

(Catalogue of Federal Domestic Assistance Program Nos. 93.392, 
Cancer Construction; 93.393, Cancer Cause and Prevention Research; 
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer 
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer 
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer 
Control, National Institutes of Health, HHS)

    Dated: April 19, 2012.
Jennifer S. Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 2012-10083 Filed 4-25-12; 8:45 am]
BILLING CODE 4140-01-P